南模生物
(688265)
| 流通市值：37.04亿 | | | 总市值：37.04亿 |
| 流通股本：7796.35万 | | | 总股本：7796.35万 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 368,573,322.95 | 232,436,961.68 | 99,917,106.36 | 421,024,337.24 |
| 营业收入 | 368,573,322.95 | 232,436,961.68 | 99,917,106.36 | 421,024,337.24 |
| 二、营业总成本 | 372,035,160.05 | 229,620,819.95 | 101,847,429.13 | 406,371,770.42 |
| 营业成本 | 172,259,085.86 | 105,730,314.17 | 46,005,201.14 | 203,399,567.65 |
| 税金及附加 | 1,673,223.39 | 1,082,446.35 | 703,486.02 | 2,703,374.2 |
| 销售费用 | 65,718,500.37 | 39,975,530.9 | 16,680,650.36 | 60,519,398.9 |
| 管理费用 | 52,929,500.91 | 35,437,508.44 | 16,360,772.16 | 51,017,223.96 |
| 研发费用 | 75,250,630.83 | 44,362,643.8 | 20,461,429.8 | 86,688,501.84 |
| 财务费用 | 4,204,218.69 | 3,032,376.29 | 1,635,889.65 | 2,043,703.87 |
| 其中:利息费用 | 1,561,869.62 | 1,076,484.85 | 556,554.21 | 2,415,789.51 |
| 其中:利息收入 | 2,294,150.86 | 1,580,912.56 | 638,286.43 | 2,576,854.68 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 10,774,586.24 | 7,704,944.58 | 3,734,189.83 | 17,682,289.12 |
| 加:投资收益 | 712,257.82 | 589,073.61 | 501,606.26 | 1,775,193.98 |
| 资产处置收益 | - | - | - | 38,969.27 |
| 资产减值损失(新) | -5,561,899.3 | -3,837,895.8 | -2,025,965.64 | -2,099,198.48 |
| 信用减值损失(新) | -4,772,388.1 | -4,524,298.52 | -2,337,183.8 | -10,163,116.15 |
| 其他收益 | 8,482,481.18 | 5,164,551.52 | 2,511,455.7 | 8,101,370.69 |
| 四、营业利润 | 6,173,200.74 | 7,912,517.12 | 453,779.58 | 29,988,075.25 |
| 加:营业外收入 | 9,911.51 | - | - | 356.07 |
| 减:营业外支出 | 123,859 | 57,869 | 57,869 | 887,300.77 |
| 五、利润总额 | 6,059,253.25 | 7,854,648.12 | 395,910.58 | 29,101,130.55 |
| 减:所得税费用 | -1,666,756.09 | -1,221,971.71 | -287,724.98 | -2,335,399.21 |
| 六、净利润 | 7,726,009.34 | 9,076,619.83 | 683,635.56 | 31,436,529.76 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 7,726,009.34 | 9,076,619.83 | 683,635.56 | 31,436,529.76 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 7,726,009.34 | 9,076,619.83 | 683,635.56 | 31,436,529.76 |
| 扣除非经常损益后的净利润 | -9,164,498.32 | -3,843,815.99 | -5,004,375.58 | 8,731,594.17 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.1 | 0.12 | 0.01 | 0.42 |
| (二)稀释每股收益 | 0.1 | 0.12 | 0.01 | 0.42 |
| 八、其他综合收益 | 63,626.27 | -95,881.77 | 17,200.94 | -277,676.1 |
| 归属于母公司股东的其他综合收益 | 63,626.27 | -95,881.77 | 17,200.94 | -277,676.1 |
| 九、综合收益总额 | 7,789,635.61 | 8,980,738.06 | 700,836.5 | 31,158,853.66 |
| 归属于母公司股东的综合收益总额 | 7,789,635.61 | 8,980,738.06 | 700,836.5 | 31,158,853.66 |
| 公告日期 | 2026-10-30 | 2026-08-29 | 2026-04-30 | 2026-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |